Open original FDA record ↗Recall record
- FDA identifier
- Z-2030-2021
- Company in FDA record
- The Binding Site Group, Ltd.
- FDA record creation date
- Jul 7, 2021
- First observed by MedTech Watch
- Nov 16, 2026
- Latest observed content change
- Nov 16, 2026
- Recall classification
- Class II
Reason stated in the source
The high and low level "Quality Controls" demonstrate a positive bias of approximately 10% compared to assigned values.
Source facts
- Action
- Between the dates of 5/20-21/2021, The Binding Site (TBS) issued a "Urgent Medical device Correction" via email to affected consignees. In addition to informing consignees about the recall, the firm ask consignees to take the following actions: 1, TBS have completed reassignment of the controls; updated target values and assigned acceptance ranges are provided in Table 2. Users may continue to use remaining kits with the following revised assigned control values. 2. Please return you completed TSWS18 E-Back Form (attached) to technical.support@bindingsite.com or to your local Binding Site representative within 5 working days of receiving this notification. Transmission of this Important information: 3. This notice needs to be passed on all those who need to be aware within your organization or to any organization where the potentially affected devices have been transferred. 4. Please transfer this notice to other organizations on which this action has an impact. 5. Please maintain awareness on this notice and resulting action for an appropriate period to ensure effectiveness of the corrective action.
- Initiated
- 2021-05-20
- Root cause
- Under Investigation by firm
- Terminated
- 2025-02-04
- Distribution
- Worldwide distribution - US Nationwide distribution in the states of CA, GA, FL, MA, MO, MI, WA, NY, PA, MN, AL, MD, OK, NE, IN, ID, OH, TX, HI, DC and the countries of Canada, Australia, Austria, Belgium, Bulgaria, Canada, Cyprus, Czech Republic, Denmark, Estonia, France, Germany, Italy, Luxembourg, Netherlands, Norway, Poland, Portugal, Romania, Slovenia, Spain, Switzerland, United Kingdom, Argentina, Egypt, GUADELOUPE, HONG KONG, India, Iran, Israel, Korea, Lebanon, Malaysia, Morocco, Oman, Singapore, Taiwan, Tunisia, Vietnam.
- Recall number
- Z-2030-2021
- Recall status
- Terminated
- CDRH record ID
- 187806
- FDA record created
- 2021-07-07
- Recall event number
- 88064